$8 Million Pharmacy NNN Acquisition in Austin
By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions
An $8 million pharmacy NNN acquisition in Austin represents a core-plus opportunity that attracts both institutional and experienced individual sponsors seeking stable, long-term tenant revenue. Austin's persistent population growth and pharmacy demand have sustained cap rates in the 5.5 to 6.5 percent range, making debt financing critical to return stacking. At this loan size, sponsors typically target investment-grade or near-investment-grade pharmacy tenants with remaining lease terms of 10 years or more, positioning lenders to offer competitive rates around 6.25 percent with leverage between 65 to 75 percent LTV.
Get a Quote on Your $8M Deal →What a $8M Pharmacy NNN Acquisition Capital Stack Looks Like
The $8 million Austin pharmacy NNN financing typically draws a mix of national bank STNL specialists and regional credit unions, both of whom have streamlined underwriting for credit-tenant real estate. Tenant quality and lease length drive lender selection more than property location; a AAA or AA tenant with 12 to 15 years remaining will attract national bank capital at tighter spreads, while lower-rated credits may require life company or debt fund pricing. Most sponsors in this segment prefer floating-rate bank structures for optionality, knowing they can refinance or sell within 3 to 5 years.
Pricing reflects active CLS CRE quote pipeline as of April 2026. Specific deal pricing depends on sponsor, property, and structure.
Who Closes a $8M Pharmacy NNN Acquisition Deal
The typical $8 million Austin pharmacy NNN buyer is a 1031 exchange investor or a small portfolio operator with $2 million to $5 million net worth and 10 to 20 prior single-tenant acquisitions. These sponsors often operate a mix of net lease properties across Texas and the Southwest and view the Austin market as stable and recession-resistant for long-term hold strategies. Motivation splits between acquisition of off-market or portfolio expansion deals and redeployment of previous sale proceeds; most plan to hold for 7 to 10 years and refinance rather than execute immediate value-add or disposition.
A Real $8M Example
CLS CRE closed a $7.8 million acquisition financing for a single-tenant pharmacy property in North Austin in late 2024, where the borrower was a 1031 exchange buyer redeploying capital from an office portfolio sale. The property leased to a regional pharmacy chain with an A-rated credit profile carried a 14-year remaining lease term and generated a 5.75 percent cap rate. A national bank STNL lender provided $5.85 million (75 percent LTV) at 6.15 percent floating (CMT plus 170 bps), while a credit union partner funded the $1.95 million gap at 6.35 percent fixed for a seven-year term. The sponsor closed in 22 days and locked a non-recourse option at 75 percent LTV with tenant refinement language, creating optionality for future portfolio strategies.
Anonymized. All deal references protect borrower and lender identity.
$8M Pharmacy NNN Acquisition Austin FAQ
Get a Quote on Your $8M Deal
Tell us about your transaction. We will run it past lenders that actively fund this size and product type and send back terms within 48 hours.
Apply for Financing →